NCT07157956 2025-09-05CVL006-T1002Convalife (Shanghai) Co., Ltd.Phase 1/2 Not yet recruiting318 enrolled
NCT02091999 2024-11-01A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4Astellas Pharma IncPhase 1 Completed213 enrolled